Association between human cytomegalovirus infection and histone acetylation level in various histological types of glioma

Huang,Rui; Qian,Dongmeng; Hu,Ming; Zhang,Xue; Song,Jingyi; Li,Ling; Chen,Hao; Wang,Bin

doi:10.3892/ol.2015.3638

Association between human cytomegalovirus infection and histone acetylation level in various histological types of glioma

Authors:
- Rui Huang
- Dongmeng Qian
- Ming Hu
- Xue Zhang
- Jingyi Song
- Ling Li
- Hao Chen
- Bin Wang
View Affiliations

Affiliations: Department of Microbiology, Qingdao University Medical College, Qingdao, Shandong 266071, P.R. China
Published online on: August 25, 2015 https://doi.org/10.3892/ol.2015.3638
Pages: 2812-2820
Copyright: © Huang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

At present, glioma is the most common intracranial tumor and accounts for 40‑60% of intracranial tumors. Glioma is highly anaplastic and demonstrates invasive growth. Although considerable progression has been achieved in the treatment of malignant glioma, the prognosis of this disease remains poor. Over the previous decade, several studies have confirmed that human cytomegalovirus (HCMV) enhances the growth or survival of tumors. This is likely to occur through mechanisms distinct from those of classic tumor viruses, which express transforming viral oncoproteins in the majority of tumor cells. The immediate‑early 2 protein (IE86; 86 kDa) of HCMV is a key regulator for viral replication and host cell proliferation. The present study aimed to identify the association between the acetylation level and HCMV IE86 expression in various histological types of glioma. Tissue samples were obtained from 60 patients with glioma, consisting of 25 patients with glioblastoma multiforme (GBM), 16 patients with anaplastic glioma and 19 patients with low‑grade glioma, in addition to 9 tissue samples obtained from the normal cortex, which were used as the control. The in situ protein expression of IE86, which is encoded by the IE2 gene, activating transcription factor 5 (ATF5), P300, acetyl‑histone H3K9 and acetyl‑histone H3K14 was detected by immunohistochemistry. The mRNA levels of ATF5, IE2 and P300 were measured by reverse transcription‑quantitative polymerase chain reaction in GBM, anaplastic glioma, low‑grade glioma and normal cortex tissue specimens. The protein levels of ATF5, IE86, P300, acetyl‑histone H3K9 and acetyl‑histone H3K14 were assessed by western blot analysis in high‑grade glioma, low‑grade glioma and normal cortex tissues. Analysis of the expression of the proteins revealed that the excessive expression of the HCMV IE86 protein is associated with the malignancy degree and acetylation level in glioma. IE86 expression is also associated with ATF5, which is an anti‑apoptotic protein that is highly expressed in malignant glioma, but not in normal brain tissues. The expression level of IE86 may demonstrate considerable importance for the evaluation of the malignancy degree of human gliomas and extensive application in diagnostic and therapeutic medicine.

View Figures

View References

1	Ranganathan P, Clark PA, Kuo JS, Salamat MS and Kalejta RF: Significant association of multiple human cytomegalovirus genomic loci with glioblastoma multiforme samples. J Virol. 86:854–864. 2012. View Article : Google Scholar : PubMed/NCBI
2	Dziurzynski K, Wei J, Qiao W, Hatiboglu MA, Kong LY, Wu A, Wang Y, Cahill D, Levine N, Prabhu S, et al: Glioma-associated cytomegalovirus mediates subversion of the monocyte lineage to a tumor propagating phenotype. Clin Cancer Res. 17:4642–4649. 2011. View Article : Google Scholar : PubMed/NCBI
3	Soroceanu L and Cobbs CS: Is HCMV a tumor promoter? Virus Res. 157:193–203. 2011. View Article : Google Scholar : PubMed/NCBI
4	Barami K: Oncomodulatory mechanisms of human cytomegalovirus in gliomas. J Clin Neurosci. 17:819–823. 2010. View Article : Google Scholar : PubMed/NCBI
5	Michaelis M, Doerr HW and Cinatl J: The story of human cytomegalovirus and cancer: Increasing evidence and open questions. Neoplasia. 11:1–9. 2009. View Article : Google Scholar : PubMed/NCBI
6	Cinatl J, Scholz M, Kotchetkov R, Vogel JU and Doerr HW: Molecular mechanisms of the modulatory effects of HCMV infection in tumor cell biology. Trends Mol Med. 10:19–23. 2004. View Article : Google Scholar : PubMed/NCBI
7	Duan YL, Ye HQ, Zavala AG, Yang CQ, Miao LF, Fu BS, Seo KS, Davrinche C, Luo MH and Fortunato EA: Maintenance of large numbers of virus genomes in human cytomegalovirus-infected T98 G glioblastoma cells. J Virol. 88:3861–3873. 2014. View Article : Google Scholar : PubMed/NCBI
8	Dziurzynski K, Chang SM, Heimberger AB, Kalejta RF, Dallas SR McGregor, Smit M, Soroceanu L and Cobbs CS: HCMV and Gliomas Symposium: Consensus on the role of human cytomegalovirus in glioblastoma. Neuro Oncol. 14:246–255. 2012. View Article : Google Scholar : PubMed/NCBI
9	Luo MH and Fortunato EA: Long-term infection and shedding of human cytomegalovirus in T98 G glioblastoma cells. J Virol. 81:10424–10436. 2007. View Article : Google Scholar : PubMed/NCBI
10	Cobbs CS, Harkins L, Samanta M, Gillespie GY, Bharara S, King PH, Nabors LB, Cobbs CG and Britt WJ: Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res. 62:3347–3350. 2002.PubMed/NCBI
11	Liu X, Liu D, Qian D, Dai J, An Y, Jiang S, Stanley B, Yang J, Wang B, Liu X and Liu DX: Nucleophosmin (NPM1/B23) interacts with activating transcription factor 5 (ATF5) protein and promotes proteasome- and caspase-dependent ATF5 degradation in hepatocellular carcinoma cells. J Biol Chem. 287:19599–19609. 2012. View Article : Google Scholar : PubMed/NCBI
12	Sheng Z, Evans SK and Green MR: An activating transcription factor 5-mediated survival pathway as a target for cancer therapy? Oncotarget. 1:457–460. 2010. View Article : Google Scholar : PubMed/NCBI
13	Angelastro JM, Canoll PD, Kuo J, Weicker M, Costa A, Bruce JN and Greene LA: Selective destruction of glioblastoma cells by interference with the activity or expression of ATF5. Oncogene. 25:907–916. 2006. View Article : Google Scholar : PubMed/NCBI
14	Liu DX, Qian D, Wang B, Yang JM and Lu Z: P300-Dependent ATF5 acetylation is essential for Egr-1 gene activation and cell proliferation and survival. Mol Cell Biol. 31:3906–3916. 2011. View Article : Google Scholar : PubMed/NCBI
15	Wang T, Qian D, Hu M, Li L, Zhang L, Chen H, Yang R and Wang B: Human cytomegalovirus inhibits apoptosis by regulating the activating transcription factor 5 signaling pathway in human malignant glioma cells. Oncol Lett. 8:1051–1057. 2014.PubMed/NCBI
16	Zhao Y, Zhang YD, Zhang YY, Qian SW, Zhang ZC, Li SF, Guo L, Liu Y, Wen B, Lei QY, et al: P300-dependent acetylation of activating transcription factor 5 enhances C/EBPβ transactivation of C/EBPα During 3T3-L1 differentiation. Mol Cell Biol. 34:315–324. 2013. View Article : Google Scholar : PubMed/NCBI
17	Wu L, Zhang X, Che Y, Zhang Y, Tang S, Liao Y, Na R, Xiong X, Liu L and Li Q: A cellular response protein induced during HSV-1 infection inhibits viral replication by interacting with ATF5. Sci China Life Sci. 56:1124–1133. 2013. View Article : Google Scholar : PubMed/NCBI
18	Nevels M, Paulus C and Shenk T: Human cytomegalovirus immediate-early 1 protein facilitates viral replication by antagonizing histone deacetylation. Proc Natl Acad Sci USA. 101:17234–17239. 2004. View Article : Google Scholar : PubMed/NCBI
19	Hwang ES, Zhang Z, Cai H, Huang DY, Huong SM, Cha CY and Huang ES: Human cytomegalovirus IE1-72 protein interacts with p53 and inhibits p53-dependent transactivation by a mechanism different from that of IE2-86 protein. J Virol. 83:12388–12398. 2009. View Article : Google Scholar : PubMed/NCBI
20	Bryant LA, Mixon P, Davidson M, Bannister AJ, Kouzarides T and Sinclair JH: The human cytomegalovirus 86-kilodalton major immediate-early protein interacts physically and functionally with histone acetyltransferase P/CAF. J Virol. 74:7230–7237. 2000. View Article : Google Scholar : PubMed/NCBI
21	Rodems SM, Clark CL and Spector DH: Separate DNA elements containing ATF/CREB and IE86 binding sites differentially regulate the human cytomegalovirus UL112-113 promoter at early and late times in the infection. J Virol. 72:2697–2707. 1998.PubMed/NCBI
22	Schwartz R, Helmich B and Spector DH: CREB and CREB-binding proteins play an important role in the IE2 86-kilodalton protein-mediated transactivation of the human cytomegalovirus 2.2-kilobase RNA promoter. J Virol. 70:6955–6966. 1996.PubMed/NCBI
23	Zhou Y, Xu Y, Wang H, Niu J, Hou H and Jiang Y: Histone deacetylase inhibitor, valproic acid, radiosensitizes the C6 glioma cell line in vitro. Oncol Lett. 7:203–208. 2014.PubMed/NCBI
24	Lois DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: World Organization Classification of tumours of the central nervous system. Acta Neuropathol. 114:97–109. 2007.PubMed/NCBI
25	Scheurer ME, Bondy ML, Aldape KD, Albrecht T and El-Zein R: Detection of human cytomegalovirus in different histological types of gliomas. Acta Neuropathol. 116:79–86. 2008. View Article : Google Scholar : PubMed/NCBI
26	Caron C, Col E and Khochbin S: The viral control of cellular acetylation signaling. Bioessays. 25:58–65. 2003. View Article : Google Scholar : PubMed/NCBI
27	Cuevas-Bennett C and Shenk T: Dynamic Histone H3 acetylation and methylation at human cytomegalovirus promoters during replication in fibroblasts. J Virol. 82:9525–9536. 2008. View Article : Google Scholar : PubMed/NCBI
28	Stinski MF and Petrik DT: Functional roles of the human cytomegalovirus essential IE86 protein. Curr Top Microbiol Immunol. 325:133–152. 2008.PubMed/NCBI
29	Taylor RT and Bresnahan WA: Human cytomegalovirus IE86 attenuates virus- and tumor necrosis factor alpha-induced NFkappaB-dependent gene expression. J Virol. 80:10763–10771. 2006. View Article : Google Scholar : PubMed/NCBI
30	Yoo YD, Chiou CJ, Choi KS, Yi Y, Michelson S, Kim S, Hayward GS and Kim SJ: The IE2 regulatory protein of human cytomegalovirus induces expression of the human transforming growth factor beta1 gene through an Egr-1 binding site. J Virol. 70:7062–7070. 1996.PubMed/NCBI
31	Sheng Z, Li L, Zhu LJ, Smith TW, Demers A, Ross AH, Moser RP and Green MR: A genome-wide RNA interference screen reveals an essential CREB3L2-ATF5-MCL1 survival pathway in malignant glioma with therapeutic implications. Nat Med. 16:671–677. 2010. View Article : Google Scholar : PubMed/NCBI
32	Liu DX, Qian D, Wang B, Yang JM and Lu Z: p300-Dependent ATF5 acetylation is essential for Egr-1 gene activation and cell proliferation and survival. Mol Cell Biol. 31:3906–3916. 2010. View Article : Google Scholar
33	Liao XH, Dong X, Wu C, Wang T, Liu F, Zhou J and Zhang TC: Human cytomegalovirus immediate early protein 2 enhances myocardin-mediated survival of rat aortic smooth muscle cells. Virus Res. 192:85–91. 2014. View Article : Google Scholar : PubMed/NCBI